Sensenbrenner Primary Care — Charlotte, North Carolina

Sensenbrenner Primary Care is a clinical research site located in Charlotte, North Carolina, United States 28277.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Sensenbrenner Primary Care has participated in 9 clinical trials.

Therapeutic areas: Cardiovascular Disease, Diabetes Type 2, Type 1 Diabetes.

Sponsors: Pfizer, Mannkind Corporation, Pfizer's Upjohn has merged with Mylan to form Viatris Inc..

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sensenbrenner Primary Care?

Sensenbrenner Primary Care has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sensenbrenner Primary Care conducted?

Sensenbrenner Primary Care has 9 clinical trials on record. Their work covers Cardiovascular Disease, Diabetes Type 2, Type 1 Diabetes.

Is Sensenbrenner Primary Care accredited by Crixeo Health?

Yes — Sensenbrenner Primary Care holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Sensenbrenner Primary Care?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.